Piramal Pharma Ltd to Hold Board Meeting for Q1 Results; Trading Window Remains Closed
Piramal Pharma Ltd has scheduled a Board of Directors meeting to review and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ending June 30, 2026. The company announced that this board meeting is set to take place on Wednesday, July 29, 2026.During the meeting, the directors are scheduled to consider the financial performance of the company as per the results released for the specified quarter.
In addition to the update regarding the board meeting, Piramal Pharma Ltd provided information concerning its trading window status. The company confirmed that the trading window, which had closed on Wednesday, July 1, 2026, will remain closed until Friday, July 31, 2026, inclusive of both days.
PPLPHARMA Stock Price Movement
As of 1:09 PM, shares of Piramal Pharma Limited are slipping by 0.86% in live trading, currently at ₹177.87 as the stock sheds ₹1.55 intraday. The equity trades within a range today, having moved between an intraday low of ₹175.1 and a high of ₹182.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.